There are 702 resources available
345P - Match-pair analysis of mFOLFIRINOX vs gemcitabine+nab-paclitaxel in advanced pancreatic ductal adenocarcinoma: Survival and toxicity outcomes
Presenter: Arpit Jain
Session: Poster Display session
346P - Final results of multicenter prospective observational study of nano-liposomal irinotecan, fluorouracil and folinic acid in second-line chemotherapy for advanced pancreatic cancer: The NAPOLEON-2
Presenter: Koshiro Toyodome
Session: Poster Display session
347P - ENHO's protective role in pancreatic adenocarcinoma
Presenter: Osama Younis
Session: Poster Display session
348P - Early-onset pancreatic cancer (EOPC) patients (pts) treated at an Italian third level referral center: A real-word artificial-intelligence (AI) analysis from the Gemelli Generator experience
Presenter: Linda DiFrancesco
Session: Poster Display session
349P - MR-guided stereotactic radiotherapy for pancreatic cancer: Results of a prospective registry study
Presenter: Mohamed Shouman
Session: Poster Display session
Impact of Chemoradiation in Periampullary Carcinoma after Whipple’s Pancreatico-duodenectomy
Presenter: Vanshika Rastogi
Session: Poster Display session
351P - Correlation between overall survival and progression-free survival in advanced pancreatic cancer: Results of NAPOLEON-1 and 2 studies
Presenter: Tsuyoshi Shirakawa
Session: Poster Display session
352P - Germline profiling of pancreatic cancer in a Middle Eastern population: A comprehensive cancer center prospective study
Presenter: Rula Amarin
Session: Poster Display session
353P - Exploring stereotactic body radiotherapy for pancreatic cancer in elderly patients: Insights from a single-center study
Presenter: Gian Marco Petrianni
Session: Poster Display session
354P - PARP inhibitors in pancreatic cancer with homologous recombination repair gene mutations: A single-institution experience
Presenter: Ruoyu Miao
Session: Poster Display session